Useful information

• Personal Injury Claim
• Road Accident Claim
• Serious Injury Claim
• Medical Negligence Claim
• Birth Injury Claim
• PIAB Application Guide
• Statute of Limitation
• No Win No Fee Guide

Vaginal mesh implants complication

If you have experienced complications as a result of a vaginal mesh implant, you may be eligible for compensation. Coleman Legal has a team of experienced solicitors currently representing several people in Ireland who have suffered complications as a result of mesh implants.

For a confidential consultation, please call us at 1800-844-104 for free or email [email protected]. You can also visit us at our 84 Talbot Street, Dublin 1, Ireland office.

Vaginal Mesh Implants – complications

The majority of women are given vaginal mesh implants to treat prolapse or incontinence.

A growing number of women have had serious complications as a result of their vaginal mesh implants, and if you have been affected by vaginal mesh implant complications in Ireland, you can discuss your situation in strict confidence with a member of our medical negligence and defective products team.

Currently, in the United Kingdom, more than 800 women are bringing an Action against the NHS and the manufacturers of their vaginal mesh implants, after suffering severe complications.

Claims made following the Transvaginal mesh procedure

Thousands of claims have been lodged against Ethicon Inc. one of the manufacturers of this device and its parent company Johnson & Johnson. These claims have alleged that the device was defective and negligently designed in that the mesh was made of polypropylene which is not safe for use in the human body.

The U.S. Food and Drug Administration (FDA) in the late 1990s and early 2000s approved transvaginal mesh implants as a treatment for pelvic organ prolapse (POP) and stress urinary incontinence (SUI). Early on, these products were embraced by doctors as a simpler, easier way to create a long-term solution for women suffering from these embarrassing and often debilitating conditions. With nearly 500,000 of these surgeries performed each year, many medical device companies saw a potentially lucrative market to enter. Since the first vaginal mesh product was approved by the FDA, dozens of vaginal mesh products have entered the market.

Paving the way for so many companies to produce multiple brands of mesh was an FDA decision to make transvaginal mesh a Class II product. This classification put a lighter burden on manufacturers to gain approval for their new products. Under Class II guidelines, and the FDA 510k program,  manufacturers are only required to show that the device they are producing is substantially similar to a product that has already been approved and is on the market. This made it very easy for manufacturers to quickly and easily bring new vaginal mesh products to market.

Although there are a large number of companies manufacturing vaginal mesh, there are five companies considered dominant in the market: Johnson & Johnson, Bard Medical, American Medical Solutions, Boston Scientific, and Coloplast. These companies produce multiple brands through multiple subsidiaries, making billions of dollars in profit every year.

Johnson & Johnson/Ethicon Transvaginal Mesh Products

Of all the mesh manufacturers, J&J’s Ethicon has been the slowest to offer settlements. The company also faces the highest number of federal lawsuits in the US.  In January 2015, the company settled four lawsuits for an undisclosed amount.

A federal jury in West Virginia awarded $3.27 million to Jo Husky in September 2014. Huskey claimed her Ethicon Gynecare TVT mesh caused permanent injuries and the company failed to warn her. In 2013, a New Jersey jury returned an $11 million verdict against Ethicon for injuries caused by its Gynecare Prolift. Another woman also won $1.2 million in Texas state court against J&J.

Drugmaker Johnson & Johnson was eager to jump into the emerging mesh market and created a new mesh product line through its subsidiary, Ethicon Inc. Ethicon was charged with developing “easy-to-use” surgical mesh kits. These kits provided doctors with pre-cut mesh and the tools needed for the implant procedure.

Surgeons embraced the convenient new kits. They quickly became the preferred treatment for prolapse and incontinence. Ethicon’s Gynecare brands were believed to be superior to traditional surgery, but doctors had many more complications than they expected. The surgical mesh was difficult to implant, and complaints of severe post-surgery complications were common.

In June 2012, amid mounting legal pressure and growing concern from the FDA, Ethicon announced that it would no longer manufacture and distribute vaginal mesh products. However, Ethicon and J&J have refused to call the decision a recall. Because of the injuries caused by these products, over 25,400 lawsuits have been filed against Ethicon and J&J in the United States alone.

Gynecare Prolift Kit

J&J started selling the Gynecare Prolift Kit for prolapse treatment in 2005 without marketing approval from the FDA. The FDA scolded J&J for breaking the rules but approved the Prolift anyway in 2008.

Gynecare TVT Secur

The Gynecare TVT Secure was the first mini bladder sling used in the United States. Instead of using needles, the U-shaped TVT Secur has built-in blades for attaching the mesh. However, the TVT Secur is more likely to loosen after surgery.

Gynecare Prosima Pelvic Floor Repair System

J&J tried to perfect the mini bladder sling with the Gynecare Prosima Kit. It uses slits cut with scissors to implant the mesh, instead of needles. A tiny balloon is then placed on top of the anchored mesh and inflated to support organs after surgery. The balloon is removed 24 hours after the operation. Because of the way it is attached, this mesh is useful only if incontinence is caused by organs dropping to the back of the vagina; it is likely to fail if organs prolapse toward the front.

Gynecare Prolift + M Kit

In another effort to avoid patient complaints of vaginal scarring and perforation J&J created the Gynecare Prolift +M to treat prolapse. It was the first surgical mesh in the United States to use plastic fibers that the body could partially absorb. This mesh isn’t as dense as the Prolift, and it has larger holes that are supposed to help patients heal after surgery. The mesh also resists folding and wrinkling. Despite J&J’s efforts, the Prolift + M eroded and shrank, just like many of its other mesh brands.

Bard Medical Transvaginal Mesh Products

Like Johnson & Johnson, Bard Medical’s brands were approved under the 510(k) process. Bard even outsourced the clinical testing for its Alyte Y-Mesh device, relying on data from a 2010 European survey of 17 surgeons to get the brand approved by the FDA. Bard makes transvaginal mesh kits for both prolapse and incontinence.

Almost 11,000 patients who received Bard transvaginal mesh have already filed lawsuits against the company for injuries related to the products. These women suffered from erosion, organ perforation, nerve damage, migrated mesh and infection caused by Bard’s brands.

Bard Transvaginal Mesh Products

Endo Pharmaceuticals/ American Medical Systems’ Transvaginal Mesh Products

American Medical Systems made mesh for both stress urinary incontinence and pelvic organ prolapse throughout the 2000s. In 2011, the company was purchased by Endo Pharmaceuticals. Some patients are suing both Endo and American Medical Systems to recover medical costs from injuries sustained from their transvaginal mesh products. Removal and revision surgeries for American Medical Systems transvaginal mesh brands happen frequently. Endo argued it could be sued for the actions of its subsidiary. However, by 2015, it had already paid close to $900 million to settle AMS lawsuits.

Boston Scientific Transvaginal Mesh Products

Boston Scientific is facing over 16,400 lawsuits over its mesh and incontinence products. Like the other manufacturers, Boston Scientific’s brands injured many patients when the faulty mesh eroded and punctured organs. The company has stated it still believes transvaginal mesh is an important treatment for incontinence and pelvic organ prolapse. Boston Scientific’s revenue was $7.6 billion in 2011, and transvaginal mesh sales made up less than 5 percent of the company’s revenue.

Coloplast Transvaginal Mesh Products

Coloplast markets mesh products for the repair of prolapse and incontinence. As of June 2015, the company is still facing almost 2,000 lawsuits, which have been consolidated in multidistrict litigation (MDL) in the U.S. District Court for the Southern District of West Virginia. The patients say Coloplast’s mesh products caused serious injury. In 2014, the Danish company offered $16 million to settle about 400 suits.

The FDA ordered dozens of manufacturers to conduct studies on their mesh products, including Johnson & Johnson/Ethicon, Bard Medical, Endo Pharmaceuticals/ American Medical Systems, Boston Scientific and Coloplast. While each company makes its own version of transvaginal mesh many of the products are similar in both their design and the material used to construct the mesh. Most transvaginal mesh brands are prone to erosion and organ perforation. Because the complaints the FDA received on mesh complications are not tied to any specific transvaginal mesh manufacturer, all companies that produce transvaginal mesh brands are potentially liable for compensating patients for injuries caused by their products.

Other Transvaginal Mesh Manufacturers and Products